227 related articles for article (PubMed ID: 12531895)
1. Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages.
Castrillo A; Joseph SB; Marathe C; Mangelsdorf DJ; Tontonoz P
J Biol Chem; 2003 Mar; 278(12):10443-9. PubMed ID: 12531895
[TBL] [Abstract][Full Text] [Related]
2. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions.
Laffitte BA; Joseph SB; Chen M; Castrillo A; Repa J; Wilpitz D; Mangelsdorf D; Tontonoz P
Mol Cell Biol; 2003 Mar; 23(6):2182-91. PubMed ID: 12612088
[TBL] [Abstract][Full Text] [Related]
3. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes.
Laffitte BA; Repa JJ; Joseph SB; Wilpitz DC; Kast HR; Mangelsdorf DJ; Tontonoz P
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):507-12. PubMed ID: 11149950
[TBL] [Abstract][Full Text] [Related]
4. Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways.
Ogawa D; Stone JF; Takata Y; Blaschke F; Chu VH; Towler DA; Law RE; Hsueh WA; Bruemmer D
Circ Res; 2005 Apr; 96(7):e59-67. PubMed ID: 15790955
[TBL] [Abstract][Full Text] [Related]
5. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors.
Joseph SB; Laffitte BA; Patel PH; Watson MA; Matsukuma KE; Walczak R; Collins JL; Osborne TF; Tontonoz P
J Biol Chem; 2002 Mar; 277(13):11019-25. PubMed ID: 11790787
[TBL] [Abstract][Full Text] [Related]
6. Liver X receptor agonists inhibit tissue factor expression in macrophages.
Terasaka N; Hiroshima A; Ariga A; Honzumi S; Koieyama T; Inaba T; Fujiwara T
FEBS J; 2005 Mar; 272(6):1546-56. PubMed ID: 15752369
[TBL] [Abstract][Full Text] [Related]
7. Transcription of the vascular endothelial growth factor gene in macrophages is regulated by liver X receptors.
Walczak R; Joseph SB; Laffitte BA; Castrillo A; Pei L; Tontonoz P
J Biol Chem; 2004 Mar; 279(11):9905-11. PubMed ID: 14699103
[TBL] [Abstract][Full Text] [Related]
8. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
Blaschke F; Takata Y; Caglayan E; Collins A; Tontonoz P; Hsueh WA; Tangirala RK
Circ Res; 2006 Dec; 99(12):e88-99. PubMed ID: 17110595
[TBL] [Abstract][Full Text] [Related]
9. Autoregulation of the human liver X receptor alpha promoter.
Laffitte BA; Joseph SB; Walczak R; Pei L; Wilpitz DC; Collins JL; Tontonoz P
Mol Cell Biol; 2001 Nov; 21(22):7558-68. PubMed ID: 11604492
[TBL] [Abstract][Full Text] [Related]
10. The arginase II gene is an anti-inflammatory target of liver X receptor in macrophages.
Marathe C; Bradley MN; Hong C; Lopez F; Ruiz de Galarreta CM; Tontonoz P; Castrillo A
J Biol Chem; 2006 Oct; 281(43):32197-206. PubMed ID: 16943198
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages.
Szanto A; Benko S; Szatmari I; Balint BL; Furtos I; Rühl R; Molnar S; Csiba L; Garuti R; Calandra S; Larsson H; Diczfalusy U; Nagy L
Mol Cell Biol; 2004 Sep; 24(18):8154-66. PubMed ID: 15340076
[TBL] [Abstract][Full Text] [Related]
12. Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors alpha and beta.
Mak PA; Laffitte BA; Desrumaux C; Joseph SB; Curtiss LK; Mangelsdorf DJ; Tontonoz P; Edwards PA
J Biol Chem; 2002 Aug; 277(35):31900-8. PubMed ID: 12032151
[TBL] [Abstract][Full Text] [Related]
13. Oxysterol and 9-cis-retinoic acid stimulate the group IIA secretory phospholipase A2 gene in rat smooth-muscle cells.
Antonio V; Janvier B; Brouillet A; Andreani M; Raymondjean M
Biochem J; 2003 Dec; 376(Pt 2):351-60. PubMed ID: 12882648
[TBL] [Abstract][Full Text] [Related]
14. Induction of transglutaminase 2 by a liver X receptor/retinoic acid receptor alpha pathway increases the clearance of apoptotic cells by human macrophages.
Rébé C; Raveneau M; Chevriaux A; Lakomy D; Sberna AL; Costa A; Bessède G; Athias A; Steinmetz E; Lobaccaro JM; Alves G; Menicacci A; Vachenc S; Solary E; Gambert P; Masson D
Circ Res; 2009 Aug; 105(4):393-401. PubMed ID: 19628791
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms involved in enhancement of matrix metalloproteinase-9 expression in macrophages by interleukin-33.
Ariyoshi W; Okinaga T; Chaweewannakorn W; Akifusa S; Nisihara T
J Cell Physiol; 2017 Dec; 232(12):3481-3495. PubMed ID: 28105703
[TBL] [Abstract][Full Text] [Related]
16. Selective activation of liver X receptors by acanthoic acid-related diterpenes.
Traves PG; Hortelano S; Zeini M; Chao TH; Lam T; Neuteboom ST; Theodorakis EA; Palladino MA; Castrillo A; Bosca L
Mol Pharmacol; 2007 Jun; 71(6):1545-53. PubMed ID: 17329499
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of lipopolysaccharide-induced gene expression by liver X receptor ligands in macrophages involves interference with early growth response factor 1.
Guillem-Llobat P; Íñiguez MA
Prostaglandins Leukot Essent Fatty Acids; 2015 May; 96():37-49. PubMed ID: 25736222
[TBL] [Abstract][Full Text] [Related]
18. Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells.
Bellosta S; Baetta R; Canavesi M; Comparato C; Granata A; Monetti M; Cairoli F; Eberini I; Puglisi L; Corsini A
Pharmacol Res; 2007 Aug; 56(2):160-7. PubMed ID: 17582780
[TBL] [Abstract][Full Text] [Related]
19. Activation of LXRs using the synthetic agonist GW3965 represses the production of pro-inflammatory cytokines by murine mast cells.
Nunomura S; Okayama Y; Matsumoto K; Hashimoto N; Endo-Umeda K; Terui T; Makishima M; Ra C
Allergol Int; 2015 Sep; 64 Suppl():S11-7. PubMed ID: 26344074
[TBL] [Abstract][Full Text] [Related]
20. The RXR agonists PA024 and HX630 have different abilities to activate LXR/RXR and to induce ABCA1 expression in macrophage cell lines.
Nishimaki-Mogami T; Tamehiro N; Sato Y; Okuhira K; Sai K; Kagechika H; Shudo K; Abe-Dohmae S; Yokoyama S; Ohno Y; Inoue K; Sawada J
Biochem Pharmacol; 2008 Oct; 76(8):1006-13. PubMed ID: 18761326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
